Tourmaline is a late-stage clinical biotechnology company driven by our mission to develop transformative medicines that establish new standards of care for patients with life-altering inflammatory and immune diseases. In doing so, we seek to develop medicines that have the potential to dramatically improve the lives of patients with high unmet medical need.
